Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement

References

• Swerdlow SH, Campo E, Harris NL, et al. World health organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
   Google Scholar
• Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer. 2011;117(11):2530–2540. doi: 10.1002/cncr.25765
   PubMed Web of Science ®Google Scholar
• Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9(6):340–350. doi: 10.1016/j.anndiagpath.2005.09.020
   PubMedGoogle Scholar
• Sanchez LA, Redondo AM, Munez OB, et al. Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities? Ann Hematol. 2015;94(4):609–616. doi: 10.1007/s00277-014-2256-0
   PubMed Web of Science ®Google Scholar
• Miyazaki K. Treatment of diffuse large B-cell lymphoma. J Clin Exp Hematopathol. 2016;56(2):79–88. doi: 10.3960/jslrt.56.79
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. New Engl J Med. 1993;329(14):987–994. doi: 10.1056/NEJM199309303291402
   PubMed Web of Science ®Google Scholar
• Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rep. 1977;61(6):1023–1027.
   PubMedGoogle Scholar
• Vargo JA, Gill BS, Balasubramani GK, et al. Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: do we still need consolidative radiotherapy? J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33(32):3710–3717. doi: 10.1200/JCO.2015.61.7654
   PubMed Web of Science ®Google Scholar
• Yahalom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2015;92(1):11–31. doi: 10.1016/j.ijrobp.2015.01.009
   PubMed Web of Science ®Google Scholar
• Ng AK, Dabaja BS, Hoppe RT, et al. Re-examining the role of radiation therapy for diffuse large B-cell lymphoma in the modern Era. J Clini Oncol: Off J Am Soc Clini Oncol. 2016;34(13):1443–1447. doi: 10.1200/JCO.2015.64.9418
   PubMed Web of Science ®Google Scholar
• Mian M, Capello D, Ventre MB, et al. Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study). Ann Hematol. 2014;93(2):221–231. doi: 10.1007/s00277-013-1856-4
   PubMed Web of Science ®Google Scholar
• American College of Surgeons. National Cancer Database. [cited 2017 May 20] Available from: https://www.facs.org/quality-programs/cancer/ncdb.
   Google Scholar
• Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-time bias. J Clini Oncol: Off J Am Soc Clin Oncol. 2013;31(23):2963–2969. doi: 10.1200/JCO.2013.49.5283
   PubMed Web of Science ®Google Scholar
• Rusthoven CG, Jones BL, Flaig TW, et al. Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2016;34(24):2835–2842. doi: 10.1200/JCO.2016.67.4788
   PubMed Web of Science ®Google Scholar
• Sehn LH. Chemotherapy alone for localized diffuse large B-cell lymphoma. Cancer J (Sudbury, Mass). 2012;18(5):421–426. doi: 10.1097/PPO.0b013e31826c5907
   PubMed Web of Science ®Google Scholar
• Longo DL. Combined-modality therapy for early-stage diffuse large B-cell lymphoma: knowing when to quit. J Clin Oncol: Off J Am Soc Clin Oncol. 2015;33(32):3684–3685. doi: 10.1200/JCO.2015.63.0285
   PubMed Web of Science ®Google Scholar
• Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. New Engl J Med. 1998;339(1):21–26. doi: 10.1056/NEJM199807023390104
   PubMed Web of Science ®Google Scholar
• Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. New Engl J Med. 2005;352(12):1197–1205. doi: 10.1056/NEJMoa042040
   PubMed Web of Science ®Google Scholar
• Miller TP, Leblanc M, Spier C, et al. CHOP alone compared to CHOP plus radiotherapy for early aggressive non-Hodgkin’s lymphoma: update of the Southwest oncology group (SWOG) randomized trial. Blood. 2001;98(11):724–725.
   Web of Science ®Google Scholar
• Haque W, Dabaja B, Tann A, et al. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: a population-based analysis. Radiother Oncol: J Eur Soc Ther Radiol Oncol. 2016;120(1):150–155. doi: 10.1016/j.radonc.2016.05.027
   PubMed Web of Science ®Google Scholar
• Ballonoff A, Rusthoven KE, Schwer A, et al. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2008;72(5):1465–1471. doi: 10.1016/j.ijrobp.2008.02.068
   PubMed Web of Science ®Google Scholar
• Phan J, Mazloom A, Medeiros LJ, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(27):4170–4176. doi: 10.1200/JCO.2009.27.3441
   PubMedGoogle Scholar
• Marcheselli L, Marcheselli R, Bari A, et al. Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma. Leukemia Lymphoma. 2011;52(10):1867–1872. doi: 10.3109/10428194.2011.585526
   PubMed Web of Science ®Google Scholar
• Held G, Zeynalova S, Murawski N, et al. Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement. J Clin Oncol: Off J Am Soc Clin Oncol. 2013;31(32):4115–4122. doi: 10.1200/JCO.2012.48.0467
   PubMed Web of Science ®Google Scholar
• Shi Z, Das S, Okwan-Duodu D, et al. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86(3):569–577. doi: 10.1016/j.ijrobp.2013.02.007
   PubMed Web of Science ®Google Scholar
• Held G, Murawski N, Ziepert M, et al. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol: Off J Am Soc Clin Oncol. 2014;32(11):1112–1118. doi: 10.1200/JCO.2013.51.4505
   PubMed Web of Science ®Google Scholar
• Dabaja BS, Vanderplas AM, Crosby-Thompson AL, et al. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the national comprehensive cancer network lymphoma outcomes project. Cancer. 2015;121(7):1032–1039. doi: 10.1002/cncr.29113
   PubMed Web of Science ®Google Scholar
• Kwon J, Kim IH, Kim BH, et al. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys. 2015;92(1):91–98. doi: 10.1016/j.ijrobp.2014.12.042
   PubMed Web of Science ®Google Scholar
• Parikh RR, Yahalom J. Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy. Leukemia Lymphoma. 2017;58(3):614–622. doi: 10.1080/10428194.2016.1205739
   PubMed Web of Science ®Google Scholar
• Hu CD C, Zou W, Zhang G, et al. The role of consolidative radiotherapy after a complete response to chemotherapy in the treatment of diffuse large B-cell lymphoma in the Rituximab era: results from a systematic review with a meta-analysis. Acta Haematol. 2015;134:111–118. doi: 10.1159/000370096
   PubMed Web of Science ®Google Scholar
• Murawski N, Held G, Ziepert M, et al. The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas. Blood. 2014;124(5):720–728. doi: 10.1182/blood-2013-10-535021
   PubMed Web of Science ®Google Scholar
• Lee SF, Ng TY, Wong FCS, et al. The role of radiotherapy in early-stage primary diffuse large B-cell lymphoma of the Waldeyer ring: a retrospective cohort study. Am J Clin Oncol. 2018;41(8):802–806. doi: 10.1097/COC.0000000000000375
   Web of Science ®Google Scholar
• Niemiec M, Stryjewska-Makuch G, Janik M, et al. Head and neck lymphomas – a retrospective ten-year observation. Contemp Oncol (Poznan, Poland). 2017;21(1):66–69.
   PubMed Web of Science ®Google Scholar
• Kwak YK, Choi BO, Kim SH, et al. Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy. Medicine. 2017;96(25):e7268. doi: 10.1097/MD.0000000000007268
   PubMed Web of Science ®Google Scholar
• Hollender A, Kvaloy S, Nome O, et al. Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model. (0923-7534 (Print)). Ann Oncology. 1 July 2002;13(7):1099–1107. doi: 10.1093/annonc/mdf175
   PubMed Web of Science ®Google Scholar
• Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722–1728. doi: 10.1001/jamaoncol.2016.6905
   PubMed Web of Science ®Google Scholar
• Lerro CC, Robbins AS, Phillips JL, et al. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann Surg Oncol. 2013;20(6):1759–1765. doi: 10.1245/s10434-013-2901-1
   PubMed Web of Science ®Google Scholar